Publications by authors named "Ario Takeuchi"

Claim this Profile
A
A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol.
Takashi Matsumoto, Tokiyoshi Tanegashima, Ario Takeuchi, Keita Sasaki, Gakuto Ogawa

Jpn J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Keita Minami, Takahiro Osawa, Takahiro Kojima, Tomohiko Hara, Masatoshi Eto, Ario Takeuchi

Urol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Junji Yonese, Nobuyuki Hinata, Satoru Masui, Yasutomo Nakai, Suguru Shirotake, Ario Takeuchi

Int J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer.
Eiji Kashiwagi, Masaki Shiota, Hidekazu Naganuma, Keisuke Monji, Kenjiro Imada, Ario Takeuchi

Int J Urol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide.
Eiji Kashiwagi, Masaki Shiota, Ken Lee, Keisuke Monji, Hidekazu Naganuma, Ario Takeuchi

JMA J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of models predicting lymph node involvement probability in patients with prostate cancer.
Leandro Blas, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Ario Takeuchi

Int J Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Mizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, Shintaro Narita, Yoshiaki Yamamoto, Ario Takeuchi

Cancer Immunol Immunother· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer.
Shigetomo Yamada, Masaki Shiota, Leandro Blas, Takashi Matsumoto, Eiji Kashiwagi, Ario Takeuchi

Prostate Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients.
Hiroki Kobayashi, Masaki Shiota, Nobuaki Sato, Satoshi Kobayashi, Takashi Matsumoto, Ario Takeuchi

Anticancer Drugs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of survival outcomes in first-line therapy for metastatic castration-resistant prostate cancer.
Masaki Shiota, Leandro Blas, Satoshi Kobayashi, Takashi Matsumoto, Eiji Kashiwagi, Ario Takeuchi

Int J Urol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors.
Takashi Matsumoto, Masaki Shiota, Shigetomo Yamada, Leandro Blas, Hidekazu Naganuma, Ario Takeuchi

JMA J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.
Leandro Blas, Kosuke Ieiri, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Ario Takeuchi

Anticancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.
Shohei Nagakawa, Masaki Shiota, Naohiro Fujimoto, Yoshiaki Yamamoto, Leandro Blas, Ario Takeuchi

Urol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and future perspectives of immunotherapy against urothelial and kidney cancer.
Takashi Kobayashi, Ario Takeuchi, Hiroyuki Nishiyama, Masatoshi Eto

Jpn J Clin Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.
Leandro Blas, Masaki Shiota, Shigetomo Yamada, Kosuke Ieiri, Shohei Nagakawa, Ario Takeuchi

Anticancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.
Takashi Morisaki, Takafumi Morisaki, Makoto Kubo, Hideya Onishi, Tatsuya Hirano, Ario Takeuchi

Anticancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of prior local therapy in castration-resistant prostate cancer.
Mikifumi Koura, Masaki Shiota, Shohei Ueda, Takashi Matsumoto, Satoshi Kobayashi, Ario Takeuchi

Jpn J Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors.
Asako Machidori, Masaki Shiota, Satoshi Kobayashi, Takashi Matsumoto, Keisuke Monji, Ario Takeuchi

Urol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma.
Yasutomo Nakai, Ario Takeuchi, Takahiro Osawa, Takahiro Kojima, Tomohiko Hara

J Geriatr Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical advantages of robot-assisted partial nephrectomy versus laparoscopic partial nephrectomy in terms of global and split renal functions: A propensity score-matched comparative analysis.
Satoshi Kobayashi, Jun Mutaguchi, Eiji Kashiwagi, Ario Takeuchi, Masaki Shiota

Int J Urol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Impact of Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer.
Masaki Shiota, Naohiro Fujimoto, Takashi Matsumoto, Shigehiro Tsukahara, Shohei Nagakawa, Ario Takeuchi

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort.
Keita Tamura, Takahiro Osawa, Ario Takeuchi, Keita Minami, Yasutomo Nakai

Jpn J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy: a case report.
Hiroki Kobayashi, Satoshi Kobayashi, Masaki Shiota, Dai Takamatsu, Tatsuro Abe, Ario Takeuchi

Int Cancer Conf J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Takuya Yamashita, Masaki Shiota, Asako Machidori, Satoshi Kobayashi, Takashi Matsumoto, Ario Takeuchi

Cancer Invest· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression.
Masaki Shiota, Yohei Sekino, Shigehiro Tsukahara, Tatsuro Abe, Fumio Kinoshita, Ario Takeuchi

Cancer Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis